Merrimack Pharmaceuticals Inc. diskutieren
Merrimack Pharmaceuticals Inc.
WKN: A2DW3Q / Symbol: MACK / Name: Merrimack Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
3,98 €
-0,50 %
DERFY stimmt dem Sentiment von 'Buy' zu
DERFY stimmt am 24.01.2017 dem Buy-Gesamtsentiment mit dem Kursziel 8.19$ zu.
(Laufzeit überschritten)
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for MACK provided by MarketBeat
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for MACK provided by MarketBeat
Neueste Beiträge
StockNews_com in Concord Medical Serv. ADR diskutieren